Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL208P is one of hundreds of 7SL RNA-like pseudogene sequences dispersed throughout the human genome[2][6][7]. These pseudogenes arose by reverse transcription and subsequent integration of 7SL RNA or its derivatives back into DNA, resulting in truncated, typically non-expressed loci lacking the capability to function as the canonical 7SL RNA[2][7]. The authentic 7SL RNA is itself an essential scaffold of the SRP ribonucleoprotein complex, mediating co-translational translocation of proteins across the endoplasmic reticulum and playing roles in ribosomal translation arrest and protein targeting[1][3][5]. However, RN7SL208P displays hallmark features of pseudogenes—such as truncations and absence of functional expression—meaning it is not involved in SRP function or recognized biological processes[2][7]. In summary, RN7SL208P is a pseudogene of the 7SL RNA and not a functional molecular target, receptor, or druggable entity. It should not be considered for therapeutic targeting or molecular pharmacology analyses[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 208, pseudogene (RN7SL208P).